未來心理健康管理

The Future of Mental Health Management

出版日期: 2023年06月22日 | 出版商:

Frost & Sullivan | 英文 71 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

心理健康管理創新文化：補充現有治療方法以提高療效和可及性

儘管心理健康狀況會縮短人們的壽命，但心理健康往往排在身體健康之後。在 COVID-19 大流行以及其他地緣政治局勢和自然災害導致焦慮和抑鬱病例增加後，這種情況慢慢改變。隨著認知的提高，新的治療方法不斷出現，可以補充現有的治療方法以獲得更好的效果。

心理健康問題很難治療。這是因為單一症狀有多種原因，包括環境和遺傳因素，並以多種方式表現出來。因此，結合多種療法可能會提供更好的結果，而不是使用單一療法。心理治療和藥物治療已經存在多年，但現在更先進的診斷和治療技術導致遠程醫療諮詢、虛擬實境、人工智慧/機器學習和症狀管理的使用。事實證明，它對行動不便的人有益。進入診所，包括使用穿戴式設備來檢測並通知醫護人員。這些先進技術有助於彌合護理差距，全天為患者提供服務，而不僅僅是在緊急情況下。研究人員還在研究生物標記物和其他診斷工具，這些工具可以超越傳統的隨時間監測症狀的方法來檢測精神狀態。

精神藥物領域也進行許多開發。通常用於改善大腦功能的精神藥物無需醫生處方即可獲得。微生物組療法和天然存在的物質也是其治療潛力研究的領域。

本報告確定了該行業成長的挑戰、促進因素和機遇，以幫助確定成長預測。它還調查相關人員生態系統並確定值得注意的合併、收購和合作夥伴關係。最後，它詳細介紹了相關人員和市場相關人員可用的融資情況。

心理健康障礙：簡介
心理健康的治療方法
基於藥物的心理健康治療干涉
精神分裂症研究概述
焦慮症研究概述
抑鬱症研究概述
BD研究概述
飲食失調、睡眠障礙、創傷後壓力症候群、藥物濫用 BD Research
心理健康領域的未來創新
健腦膳食補充劑/精神藥物
適合所有年齡段的遠程醫療服務
用於自助、冥想和正念的行動應用程式
用於心理健康管理的虛擬實境、人工智慧和機器學習
精神健康狀況的診斷和生物標記的開發
創新生態系統概覽

規定

歐洲和美國的心理健康狀況
亞太地區 (APAC) 國家的心理健康狀況
亞太地區 (APAC) 國家和中東地區的心理健康狀況
其他國家的心理健康狀況

知識產權（IP）

心理健康專利格局
知識產權申請分析：要點

充滿成長機會的宇宙

成長機會1：透過AI/ML/VR補充處方治療，以獲得更好的心理健康管理成果
成長機會2：開發靶向處方療法
成長機會3：基於有效性證據的心理健康應用基準測試

下一步

下一步
現在為何選擇 Frost & Sullivan？
免責聲明

簡介目錄

Product Code: DAA7

An Innovation Culture in Mental Health Management Complements Current Therapies for Improved Efficacy and Access to Care

Mental health conditions reduce people's life expectancy-yet mental health takes a distant second place to physical health in many instances. This is slowly changing after the COVID-19 pandemic triggered rising cases of anxiety and depression, as have other geopolitical conditions and natural calamities. With rising awareness, new treatments emerge that can complement existing therapies for better outcomes.

Treating mental health issues is challenging because a condition may have varying causes, such as environmental and genetic factors, and different symptoms present themselves in different degrees. As a result, combining therapies-instead of using a single therapy-could result in better efficacy. Psychotherapy and medication have been long-standing treatment methods, and now more advanced techniques for diagnosis and treatment can prove beneficial for people with limited access to a clinic, like telehealth consultations or the use of virtual reality, artificial intelligence/machine learning, and the use of wearables for detecting a symptom and notifying a medical professional. These advanced technologies help serve patients throughout the day and not just during emergencies, which closes the gaps in care. Research is also underway for biomarkers and other diagnostic tools that can detect a mental health condition, surpassing the traditional technique of monitoring symptoms for a certain period.

Much development is also undergoing in the nootropic space. Nootropics, generally used to improve brain performance, are available without a medical prescription. Microbiome therapeutics and naturally available substances are another area being explored further for therapeutic benefits.

This Frost & Sullivan report identifies the challenges, drivers, and growth opportunities in this space and helps foresee its growth outlook. It also provides an overview of the stakeholder ecosystem, identifying notable mergers, acquisitions, and partnerships. Finally, the report provides a detailed account of the funding landscape for stakeholders and market players to leverage.

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Mental Health Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Scope and Segmentation

Research Context and Scope of Analysis
Segmentation
Other Techniques for Mental Health Management

Growth Opportunity Analysis

Growth Drivers
Growth Restraints

Introduction

Introduction
The Impact of the COVID-19 Pandemic on Mental Health
Roadblocks to the Mental Health Industry's Development

Innovation Ecosystem

An Introduction to Mental Health Conditions
Treatment Approaches to Mental Health
Drug-based Therapeutic Intervention in Mental Health
A Snapshot of Schizophrenia Research
A Snapshot of Anxiety Research
A Snapshot of Depression Research
A Snapshot of BD Research
A Snapshot of Eating Disorder, Sleeping Disorder, PTSD, and Substance Use Research
Upcoming Innovations in the Field of Mental Health
Brain Boosting Nutraceuticals/Nootropics
Telehealth Services to Cater to All Age Groups
Self-help, Meditation, and Mindfulness Mobile Applications
Virtual Reality, AI and Machine Learning for Mental Health Management
Diagnostics and Biomarker Development for Mental Health Conditions
Innovation Ecosystem Summary

Regulatory

The Mental Health Landscape in Europe and the United States
The Mental Health Landscape in Select Asia-Pacific (APAC) Countries
The Mental Health Landscape in Select APAC Countries and the Middle East
The Mental Health Landscape in Other Select Countries

Intellectual Property

The Patent Landscape for Mental Health
Key Takeaways from the IP Filing Analysis

Stakeholder Ecosystem

Strategic Partnerships Between Mental Health-focused Companies
Funding Ecosystem
Mergers and Acquisitions in Mental Health Industry
Key Takeaways from the Stakeholder Ecosystem

Growth Opportunity Universe

Growth Opportunity 1: Complementing Prescription Therapies with AI/ML/VR for Better Outcomes in Mental Health Management
Growth Opportunity 2: The Development of Targeted Prescription Treatments
Growth Opportunity 3: Benchmarking Mental Health Applications Based on Efficacy Evidence